Hosted on MSN21h
Supernus’s stock sinks after depression drug fails trialSupernus Pharmaceutical’s stock declined following the release of disappointing Phase IIb trial results for SPN-820, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback